Cargando…

Establishing a Novel Gene Signature Related to Histone Modifications for Predicting Prognosis in Lung Adenocarcinoma

BACKGROUND: Epigenetic modifications have been revealed to play an important role in tumorigenesis and tumor development. This study aims to analyze the role of histone modifications and the prognostic values of histone modifications in lung adenocarcinoma (LUAD). The promoters and enhancers of prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Mengfeng, Yu, Xiran, Xu, Shidong, Qu, Changfa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525801/ https://www.ncbi.nlm.nih.gov/pubmed/36193203 http://dx.doi.org/10.1155/2022/8802573

Ejemplares similares

Characterization of lung adenocarcinoma based on immunophenotyping and constructing an immune scoring model to predict prognosis
por: Liu, Mengfeng, et al.
Publicado: (2022)

Predictive Value of Gene Databases in Discovering New Biomarkers and New Therapeutic Targets in Lung Cancer
por: Liu, Mengfeng, et al.
Publicado: (2023)

Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis
por: Jiang, Xueping, et al.
Publicado: (2020)

Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma
por: Li, Zhaodong, et al.
Publicado: (2020)

Comparative analyses of salivary exosomal miRNAs for patients with or without lung cancer
por: Liu, Mengfeng, et al.
Publicado: (2023)

Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients
por: Cai, Jingjing, et al.
Publicado: (2021)

Genetic variants in histone modification regions are associated with the prognosis of lung adenocarcinoma
por: Kang, Hyo-Gyoung, et al.
Publicado: (2021)

A Novel Immune-Related Gene Signature Predicts Prognosis of Lung Adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2022)

Comprehensive analysis of histone methylation modification regulators for predicting prognosis and drug sensitivity in lung adenocarcinoma
por: Ye, Ying, et al.
Publicado: (2022)

A novel tetraspanin-related gene signature for predicting prognosis and immune invasion status of lung adenocarcinoma
por: Zhu, Yindong, et al.
Publicado: (2023)

Cuproptosis-related gene signatures for predicting prognosis of lung adenocarcinoma
por: Ye, Wei, et al.
Publicado: (2022)

A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma
por: Lu, Yinliang, et al.
Publicado: (2022)

A novel defined cuproptosis-related gene signature for predicting the prognosis of lung adenocarcinoma
por: Zhang, Huizhe, et al.
Publicado: (2022)

Establishment of lactate-metabolism-related signature to predict prognosis and immunotherapy response in patients with colon adenocarcinoma
por: Zou, Zhengrong, et al.
Publicado: (2022)

Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
por: Lv, Yanju, et al.
Publicado: (2022)

Lipid metabolism-related gene signatures for predicting the prognosis of lung adenocarcinoma
por: Cao, Xueting, et al.
Publicado: (2023)

Establishment and validation of a ubiquitination-related gene signature associated with prognosis in pancreatic duct adenocarcinoma
por: Guo, Yangyang, et al.
Publicado: (2023)

Construction and analysis of a novel ferroptosis‐related gene signature predicting prognosis in lung adenocarcinoma
por: Zhou, Jing, et al.
Publicado: (2021)

A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma
por: Tang, Xiaolong, et al.
Publicado: (2022)

A novel methionine metabolism-related signature predicts prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Qing-Hua, et al.
Publicado: (2023)

Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma
por: Wu, Zixuan, et al.
Publicado: (2022)

A novel epithelial-mesenchymal transition-related gene signature for prognosis prediction in patients with lung adenocarcinoma
por: Feng, Shengyu, et al.
Publicado: (2022)

A Novel Signature of Lipid Metabolism-Related Gene Predicts Prognosis and Response to Immunotherapy in Lung Adenocarcinoma
por: Zhang, Kai, et al.
Publicado: (2022)

A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma
por: Wang, Xinyi, et al.
Publicado: (2023)

A novel zinc metabolism-related gene signature to predict prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2023)

Identification of a novel anoikis‐related gene signature to predict prognosis and tumor microenvironment in lung adenocarcinoma
por: Diao, Xiayao, et al.
Publicado: (2022)

An Inflammation-Related Nine-Gene Signature to Improve Prognosis Prediction of Lung Adenocarcinoma
por: Liu, Ze-jing, et al.
Publicado: (2021)

Apoptosis-Related Signature Predicts Prognosis and Immune Microenvironment Infiltration in Lung Adenocarcinoma
por: Zou, Xiaoli, et al.
Publicado: (2022)

A Cell Differentiation Trajectory-Related Signature for Predicting the Prognosis of Lung Adenocarcinoma
por: Yang, Fan, et al.
Publicado: (2022)

Establishment and Validation of a Ferroptosis-Related Gene Signature to Predict Overall Survival in Lung Adenocarcinoma
por: Wang, Su, et al.
Publicado: (2022)

Establishment and Validation of a Ferroptosis-Related Long Non-Coding RNA Signature for Predicting the Prognosis of Stomach Adenocarcinoma
por: Zhang, Shuqiong, et al.
Publicado: (2022)

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
por: Shu, Jianfeng, et al.
Publicado: (2023)

A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma
por: Zhai, Wen-Yu, et al.
Publicado: (2022)

A Novel Mitochondrial-Related Gene Signature for the Tumor Immune Microenvironment Evaluation and Prognosis Prediction in Lung Adenocarcinoma
por: Li, Yin-ping, et al.
Publicado: (2022)

A novel pyroptosis related genes signature for predicting prognosis and estimating tumor immune microenvironment in lung adenocarcinoma
por: Wu, Chunting, et al.
Publicado: (2022)

A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma
por: Fang, Xueying, et al.
Publicado: (2022)

A novel anoikis-related gene signature to predict the prognosis, immune infiltration, and therapeutic outcome of lung adenocarcinoma
por: Wang, Yanyan, et al.
Publicado: (2023)

Clinical and functional significance of a novel ferroptosis‐related prognosis signature in lung adenocarcinoma
por: Wang, Ziqi, et al.
Publicado: (2021)

A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis
por: Bian, Chengyu, et al.
Publicado: (2022)

Immune‐related eight‐lncRNA signature for improving prognosis prediction of lung adenocarcinoma
por: Chen, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9rsfan8uum5dlsrdtdl7bk7dk2